The role of breast cancer stem cells in metastasis and therapeutic implications.
about
Salinomycin as a drug for targeting human cancer stem cellsHER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisCD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system.DNA methyltransferases: a novel target for prevention and therapy.Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerAn agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and locationAn array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosisPHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheresBioengineering embryonic stem cell microenvironments for the study of breast cancerA novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties.Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cellsInvolvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells.Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 ProteinTargeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modellingp38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.Cyclohexylmethyl Flavonoids Suppress Propagation of Breast Cancer Stem Cells via Downregulation of NANOG.Leukemia Stem Cell-Released Microvesicles Promote the Survival and Migration of Myeloid Leukemia Cells and These Effects Can Be Inhibited by MicroRNA34a Overexpression.Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells.AECHL-1 targets breast cancer progression via inhibition of metastasis, prevention of EMT and suppression of Cancer Stem Cell characteristics.Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness.Breast cancer stem cells.Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.Tissue Stiffness and Hypoxia Modulate the Integrin-Linked Kinase ILK to Control Breast Cancer Stem-like Cells.Cancer-selective death of human breast cancer cells by leelamine is mediated by bax and bak activation.Breast Cancer Stem Cell Culture and Enrichment Using Poly(ε-Caprolactone) Scaffolds.Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapyHeterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer.Methyl Antcinate A suppresses the population of cancer stem-like cells in MCF7 human breast cancer cell line.Increased invasion and tumorigenicity capacity of CD44+/CD24- breast cancer MCF7 cells in vitro and in nude mice.Evidence of lateral transmission of aggressive features between different types of breast cancer cellsMechanistic Study of Bakuchiol-Induced Anti-breast Cancer Stem Cell and in Vivo Anti-metastasis Effects.A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells.Hypoxia modulates the stem cell population and induces EMT in the MCF-10A breast epithelial cell line.Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity.Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors.A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy.
P2860
Q21285139-FE03CC3E-DDE9-47F3-AA53-FE1B2E79EF01Q28085413-9F174FCB-0B77-4D64-9836-F846870024FBQ28388257-A1CD6BBB-3772-42F9-B348-A09E409ECC6AQ30738016-5916EEC3-77BD-45AA-85BB-8677E17BD59EQ33579896-59CDF33C-F3E6-4708-AB2A-4704B2DA3687Q33686729-C0A980F9-50EB-4AF9-9680-43E9FA67111EQ33760216-68E93EE2-A5EA-48A7-9C7B-89AEB130464CQ34311859-598509F0-9BF6-4A49-9D02-4AE13F43BED4Q34491930-F2088B7E-87D5-408F-ADA6-AC39304837E0Q34765897-6E85DB60-9EA5-41ED-B3B6-856366992D1BQ35600151-B3356533-8162-4164-8261-404DB64D8CDBQ35831031-2F494D0C-A9B0-4F9A-B834-A5C28C289D8BQ36189380-08450443-CFD3-442D-9C4F-6F9FF42145DCQ36190070-DC5BF5A3-5705-4739-820E-B3C33A963010Q36574049-0BCC4DFF-3EDE-4C8F-9FB9-36B72EB7FF5FQ36685414-4CF8B2EC-730E-499A-8E78-204D94776A78Q36687990-CB020156-6277-4A50-AE4E-463FDAF8946BQ36801802-A79B3341-7A53-455A-B9BA-EB7A5CE1EA22Q36809835-29BC5C16-4A32-4C47-A8C7-BF14A0DA7189Q37079634-4BA800F0-654A-45D6-8F14-7B6A11A131D9Q37323067-D8B40C4D-99FB-489E-9BA1-AF66548F5D59Q37504407-BD1B4046-E3D0-4C84-8293-13370767597EQ37706665-67FC7B36-8C99-4E91-8B79-DE6765EB5204Q37976224-CF512D26-253A-4B9E-A4E4-863613E758D7Q38373935-76DAC5AB-738E-47E4-9623-6DE5787235B0Q38752916-A0BDDDF4-967B-4CF4-A0A2-2108FEFB6640Q38773084-ACFDF44A-DF0D-43D4-B8E7-F5846D616CC2Q38775046-9AB77E67-73E8-4ACE-A260-D4D75420C3BCQ38823095-0B487C24-B67C-45EF-B234-5F1145A28C9FQ38860946-D9751132-9BAB-48F0-8C36-6F0F8F3051D4Q39188316-A92EB02A-8B25-4A7C-9E3D-93198B003ED5Q39396696-B7FB9808-4BEF-4CE9-AEB4-60D5F3808CF9Q42378710-3D15F482-C3B2-400D-A626-45442523BFB6Q47098006-1C5EE557-94B3-4BD0-8C65-E6DC00AEEAE5Q48203969-1BD19A2E-1383-44AE-91E0-31E805784C2FQ48832449-8E9ABEA1-C6B5-416F-86B7-A2651E62FD2EQ49183949-A8A0EB9A-9919-4D48-84CA-213710C346F5Q49271132-3AFACED1-7559-4C2F-AABA-CD8A887EC302Q49619782-685CD7BF-A049-4ED2-8855-AA4FB5FF30D6Q50660018-CD2BCB7E-7AA3-48B4-B245-CEABB7B78517
P2860
The role of breast cancer stem cells in metastasis and therapeutic implications.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The role of breast cancer stem cells in metastasis and therapeutic implications.
@ast
The role of breast cancer stem cells in metastasis and therapeutic implications.
@en
type
label
The role of breast cancer stem cells in metastasis and therapeutic implications.
@ast
The role of breast cancer stem cells in metastasis and therapeutic implications.
@en
prefLabel
The role of breast cancer stem cells in metastasis and therapeutic implications.
@ast
The role of breast cancer stem cells in metastasis and therapeutic implications.
@en
P2093
P2860
P1476
The role of breast cancer stem cells in metastasis and therapeutic implications.
@en
P2093
Marco A Velasco-Velázquez
Richard G Pestell
Vladimir M Popov
P2860
P356
10.1016/J.AJPATH.2011.03.005
P407
P577
2011-04-28T00:00:00Z